Your search returned 28 results.

Results
	21.	Tasisulam sodium (LY573636 sodium) as third-line treatment in patients with unresectable, metastatic non-small-cell lung cancer: a phase-II study. [electronic resource] by Scagliotti, Giorgio V Ilaria, Robert Novello, Silvia von Pawel, J Fischer, Juergen R Ermisch, Sabine de Alwis, Dinesh P Andrews, Joan Reck, Martin Crino, Lucio Eschbach, Corinna Manegold, Christian Producer: 20120925 In: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer vol. 7 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	22.	Pembrolizumab Exposure-Response Assessments Challenged by Association of Cancer Cachexia and Catabolic Clearance. [electronic resource] by Turner, David C Kondic, Anna G Anderson, Keaven M Robinson, Andrew G Garon, Edward B Riess, Jonathan Wesley Jain, Lokesh Mayawala, Kapil Kang, Jiannan Ebbinghaus, Scot W Sinha, Vikram de Alwis, Dinesh P Stone, Julie A Producer: 20191118 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 24 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	23.	A phase I study of tasisulam sodium (LY573636 sodium), a novel anticancer compound in patients with refractory solid tumors. [electronic resource] by Simon, George R Ilaria, Robert L Sovak, Mika A Williams, Charles C Haura, Eric B Cleverly, Ann L Sykes, Amanda K Wagner, Margaret M de Alwis, Dinesh P Slapak, Christopher A Miller, Mary A Spriggs, David R Producer: 20111227 In: Cancer chemotherapy and pharmacology vol. 68 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	24.	A phase I trial of a potent P-glycoprotein inhibitor, Zosuquidar.3HCl trihydrochloride (LY335979), administered orally in combination with doxorubicin in patients with advanced malignancies. [electronic resource] by Rubin, Eric H de Alwis, Dinesh P Pouliquen, Isabelle Green, Lisa Marder, Phil Lin, Yong Musanti, Rita Grospe, Stephanie L Smith, Sharon L Toppmeyer, Deborah L Much, Judy Kane, Michael Chaudhary, Ajai Jordan, Christopher Burgess, Michael Slapak, Christopher A Producer: 20030121 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 8 Availability: No items available. Save to lists Add to cart (remove)
	25.	Phase I study of docetaxel in combination with the P-glycoprotein inhibitor, zosuquidar, in resistant malignancies. [electronic resource] by Fracasso, Paula M Goldstein, Lori J de Alwis, Dinesh P Rader, Janet S Arquette, Matthew A Goodner, Sherry A Wright, Lisa P Fears, Carole L Gazak, Robert J Andre, Valerie A M Burgess, Michael F Slapak, Christopher A Schellens, Jan H M Producer: 20050503 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	26.	Modelling the genesis and treatment of cancer: the potential role of physiologically based pharmacodynamics. [electronic resource] by Steimer, Jean-Louis Dahl, Svein G De Alwis, Dinesh P Gundert-Remy, Ursula Karlsson, Mats O Martinkova, Jirina Aarons, Leon Ahr, Hans-Jürgen Clairambault, Jean Freyer, Gilles Friberg, Lena E Kern, Steven E Kopp-Schneider, Annette Ludwig, Wolf-Dieter De Nicolao, Giuseppe Rocchetti, Maurizio Troconiz, Iñaki F Producer: 20100325 In: European journal of cancer (Oxford, England : 1990) vol. 46 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	27.	Baseline Tumor Size Is an Independent Prognostic Factor for Overall Survival in Patients with Melanoma Treated with Pembrolizumab. [electronic resource] by Joseph, Richard W Elassaiss-Schaap, Jeroen Kefford, Richard Hwu, Wen-Jen Wolchok, Jedd D Joshua, Anthony M Ribas, Antoni Hodi, F Stephen Hamid, Omid Robert, Caroline Daud, Adil Dronca, Roxana Hersey, Peter Weber, Jeffrey S Patnaik, Amita de Alwis, Dinesh P Perrone, Andrea Zhang, Jin Kang, S Peter Ebbinghaus, Scot Anderson, Keaven M Gangadhar, Tara C Producer: 20191118 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 24 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	28.	Correction: Baseline Tumor Size Is an Independent Prognostic Factor for Overall Survival in Patients with Melanoma Treated with Pembrolizumab. [electronic resource] by Joseph, Richard W Elassaiss-Schaap, Jeroen Kefford, Richard Hwu, Wen-Jen Wolchok, Jedd D Joshua, Anthony M Ribas, Antoni Hodi, F Stephen Hamid, Omid Robert, Caroline Daud, Adil Dronca, Roxana Hersey, Peter Weber, Jeffrey S Patnaik, Amita de Alwis, Dinesh P Perrone, Andrea Zhang, Jin Kang, S Peter Ebbinghaus, Scot Anderson, Keaven M Gangadhar, Tara C Publication details: Clinical cancer research : an official journal of the American Association for Cancer Research Dec 2018 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 24 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)